Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids

Health Affairs
Yongbin LiZuxun Lu

Abstract

In appropriate prescribing is a global problem. It is especially salient in China, where drug sales constitute a major portion of health care providers' incomes, price distortions are rampant, and oversight is lax. However, few data exist on the prevalence of inappropriate prescribing in China. This study, the first of its kind in China, examined 230,800 prescriptions written between 2007 and 2009 by 784 community health institutions in 28 cities across China. The data show substantial overprescribing, including twice as many prescriptions for antibiotics as recommended by the World Health Organization and rates of injection that are three times higher than in similar countries. These findings point to the need to integrate rational prescribing into China's ongoing health care reform.

References

Oct 28, 1999·Health Policy and Planning·A le GrandF M Haaijer-Ruskamp
Mar 10, 2001·Health Policy and Planning·R LaingD Ross-Degnan
Jun 8, 2010·BMC Health Services Research·Jing XuZuxun Lu

❮ Previous
Next ❯

Citations

Jun 15, 2013·International Journal for Equity in Health·Qian LongShenglan Tang
Feb 20, 2016·The Journal of Antimicrobial Chemotherapy·Hai LinCecilia Stålsby Lundborg
Apr 1, 2015·Health Policy and Planning·Yanhong GongZuxun Lu
Mar 5, 2016·Health Economics·Xiaojie SunQingyue Meng
Apr 29, 2016·Journal of Market Access & Health Policy·Yixi ChenMondher Toumi
Jul 10, 2013·Health Economics·Gang ChenBruce Hollingsworth
Sep 8, 2015·Social Science & Medicine·Felicity Thomas, Michael Depledge
Mar 25, 2016·Scientific Reports·Yu BaiZuxun Lu
Nov 26, 2015·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Neil Munro, Jane Duckett
Nov 21, 2013·The Lancet Infectious Diseases·Ramanan LaxminarayanOtto Cars
Sep 15, 2014·Social Science & Medicine·Chun ChenMo Hao
Jan 23, 2015·BMC Health Services Research·Wenjie ZengBrian Godman
Sep 1, 2014·Journal of Development Economics·Janet CurrieJuanjuan Meng
Mar 21, 2015·PloS One·Wenhui MaoShenglan Tang
Apr 12, 2017·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Zheng WangTian Yang
Feb 1, 2017·Chinese Medical Journal·Chuan YangZi-Jun Zhou
Jan 26, 2017·Academic Medicine : Journal of the Association of American Medical Colleges·Dan Wu, Tai Pong Lam
Feb 25, 2014·Qualitative Health Research·Jonathan PenmBetty Chaar
Jul 12, 2016·International Journal of Environmental Research and Public Health·Ding DingGuoxiang Liu
Apr 16, 2018·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jiancong WangWalter Zingg
Oct 13, 2017·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Dan WuKai Sing Sun
Jun 4, 2015·Emerging Microbes & Infections·Vincent Cc ChengKwok-Yung Yuen
Feb 17, 2018·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Su WangChen-Rong Mi
Feb 11, 2018·PharmacoEconomics Open·Sachiko OzawaManuela Villar Uribe
May 17, 2019·Applied Health Economics and Health Policy·Shui Ling WongSalbiah Mohd Salleh
Jul 10, 2019·International Journal of Environmental Research and Public Health·Chenxi LiuXinping Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.